The follow-up brought little surprise, with investigators pleased the risk of death/disabling stroke remained on par with ...

Findings from the first 500 patients treated with the Trilogy system met noninferiority for both safety and efficacy.

Experts are dismayed, disappointed, and confused, but many say this isn’t the end of cerebral embolic protection for TAVI.

Patients with aortic stenosis were excluded from earlier trials of the SGLT2 inhibitor, but new data confirm they too can ...

There are worries about delayed complications, but many places won’t get paid if AF patients don’t spend the night in ...

Injectable semaglutide has better bioavailability, researchers say, but the many patients who want an oral drug are an unmet ...

While the exact mechanism is unknown, the data suggest a multitude of benefits independent of large weight loss.

On top of noninferior efficacy, the trial showed patients had less bleeding with 2.5 mg vs 5.0 mg twice daily over 12 months.

Bouffant caps, beard covers, and more—the idea is to prevent infection. Some say the requirements are overkill.

With regional differences in which name is used for the aortic fix, some say unity is needed. Others can live with both.

Applying ultrasound to help break up thrombus during carotid endarterectomy reduces adverse neurological outcomes in the ...

Among successful revascularizations, there was a hint of better outcomes compared with OMT, but the data need confirmation.